| « Putin has no doubts China will be the world’s largest economy in coming years | Venezuela Signs $3.2 Billion Debt Restructuring Deal With Russia » |
fda-approves-new-digital-sensor-ensure-patients-mental-health-issues-take-their-meds
The Food and Drug Administration has just approved a new pill with a digital sensor in it. Regulators in the United States have approved the first pill that can be digitally tracked as it makes its way through the human body. The Abilify MyCite aripiprazole tablets used for treating schizophrenia and manic episodes have an ingestible sensor embedded inside them that records that the medication has been taken. A patch worn by the patient transmits this information to their smartphone .Abilify MyCite features a sensor the size of a grain of sand made of silicon, copper, and magnesium. An electrical signal is activated when the sensor comes into contact with stomach acid - the sensor then passes through the body naturally.
A patch the patient wears on their left rib cage receives the signal several minutes after the pill is ingested. The patch then sends data like the time the pill was taken and the dosage to a smartphone app over Bluetooth.
The patch also records activity levels, sleeping patterns, steps taken, activity, and heart rate, and must be replaced every seven days. The patient’s doctor and up to four other people chosen by the patient, including family members, can access the information. The patient can revoke access at any time.
No feedback yet
